The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers
|Study ID||Alternative Stable ID||Type|
WES and clonality characterization of different timepoints in HER2-negative primary breast cancers receiving neoadjuvant eribulin therapy.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Temporal HER2-negative breast cancers WES
|Illumina HiSeq 2500||94|